Roivant Sciences Ltd:牛皮癣3期顶线数据与干燥综合征3期研究启动预计于2026年下半年公布

美股速递
Apr 02

Roivant Sciences Ltd.近日披露了其研发管线的重要进展时间表。根据公司规划,针对牛皮癣(Niu)适应症的3期临床试验顶线数据,以及针对干燥综合征(Cs)适应症的3期研究启动,均预计在2026年下半年的日历年内完成。

这一系列关键节点的设定,标志着公司在自身免疫性疾病领域的研发进入了加速阶段。两项研究的推进,将为Roivant Sciences Ltd.的核心产品线带来重要的临床验证,并可能为未来的商业化奠定基础。市场投资者正密切关注这些里程碑事件,它们对公司估值和长期发展前景具有潜在的重大影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10